Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,421 | -8,908 | 6,837 | 6,758 | -1,118 |
| Depreciation Amortization | 4,516 | 12,986 | 8,375 | 4,710 | 1,710 |
| Income taxes - deferred | -599 | -20,127 | -17,540 | -12,552 | N/A |
| Accounts receivable | -1,083 | -10,132 | -7,140 | -8,494 | -2,663 |
| Accounts payable and accrued liabilities | -3,231 | 2,018 | 1,368 | -2,790 | 604 |
| Other Working Capital | -6,913 | -2,258 | -7,770 | -11,513 | -383 |
| Other Operating Activity | 6,807 | 21,828 | 12,051 | 17,979 | 3,670 |
| Operating Cash Flow | $-7,924 | $-4,593 | $-3,819 | $-5,902 | $1,820 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,456 | -8,380 | -6,797 | -4,406 | -1,717 |
| Net Acquisitions | N/A | 1,559 | 1,559 | 43 | N/A |
| Other Investing Activity | -814 | -6,371 | -5,412 | -4,280 | -2,710 |
| Investing Cash Flow | $-2,270 | $-13,192 | $-10,650 | $-8,643 | $-4,427 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 27,306 | 26,450 | 11,800 | N/A |
| Debt Issued | N/A | 1,550 | 1,640 | 1,282 | 1,052 |
| Debt Repayment | -125 | -214 | N/A | N/A | N/A |
| Common Stock Issued | 257 | 1,418 | 1,017 | 608 | 243 |
| Other Financing Activity | -313 | -32,838 | -29,780 | -13,305 | -79 |
| Financing Cash Flow | $-181 | $-2,778 | $-673 | $385 | $1,216 |
| Exchange Rate Effect | -22 | -23 | -163 | 3 | N/A |
| Beginning Cash Position | 69,870 | 90,456 | 90,456 | 90,456 | 90,456 |
| End Cash Position | 59,473 | 69,870 | 75,151 | 76,299 | 89,065 |
| Net Cash Flow | $-10,397 | $-20,586 | $-15,305 | $-14,157 | $-1,391 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,924 | -4,593 | -3,819 | -5,902 | 1,820 |
| Capital Expenditure | -1,456 | -8,385 | -6,819 | -4,407 | -1,720 |
| Free Cash Flow | -9,380 | -12,978 | -10,638 | -10,309 | 100 |